Historic price reductions will allow millions more people to receive TB prevention, treatment and testing.

A study of tuberculosis (TB) patients in South Africa found that more than half receiving treatment with a bedaquiline-containing regimen had isolates with bedaquiline resistance, researchers reported in The Lancet Microbe.

Key takeaways:

RESIST-TB released its November 2023 newsletter with the latest updates and research publications on drug-resistant TB.

The World Health Organization releases updated Target Regimen Profiles for TB treatment and new Target Product Profiles for tests for TB treatment monitoring and optimization.

In our newly released Partnership Report, we highlight how the Global Fund and Unitaid collaborate to accelerate equitable access to lifesaving health products that prevent, detect and treat HIV, TB and malaria. By combining Unitaid’s investments in innovative new health products with the Global Fund’s proven ability to take those tools to scale around the world, we increase return on investment, save more lives and reach the health-related Sustainable Development Goals more quickly.

Exposure to isoniazid prevention therapy during the first trimester of pregnancy is associated with increased risk for fetal demise, according to study results published in Clinical Infectious Diseases.

1 November, Geneva, Switzerland – The Stop TB Partnership today has launched its 10^th edition of the Step Up for TB (SUFT) survey report that summarizes the present policy landscape of 20 high-burden countries (HBC) for tuberculosis (TB).

• Some 240,000 children worldwide die of tuberculosis every year, because the disease is often misdiagnosed or not diagnosed in time.
• An international research consortium led by LMU has now tested a rapid new analytical tool with partners in South Africa, Malawi, Tanzania, Mozambique, and India.
• The tool, which needs just a small blood sample from the fingertip, has the potential to significantly improve the diagnosis of tuberculosis in children.

Munich, 31 October 2023 – Around 240,000 children worldwide die of tuberculosis every year. The disease is among the top ten causes of death in children under the age of five. One of the main reasons for this mortality is that tuberculosis is often misdiagnosed or not diagnosed in time, particularly in regions with limited resources. A new diagnostic tool, which an international research consortium led by LMU medical scientists Laura Olbrich and Norbert Heinrich from the Division of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich has tested as part of a large-scale study in five countries, offers significant progress in this area. The authors report on their findings in The Lancet Infectious Diseases.

The Lancet Global Health journal published two papers on October 30 showing the effectiveness and health economical impact of community-based intervention for household child contact management. Led by the French National Research Institute for Sustainable Development (IRD), the CONTACT study for COmmunity iNtervention for Tuberculosis Active Contact Tracing and preventive therapy, was part of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)'s CaP-Tuberculosis (TB) Project.